Navigation Links
Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
Date:2/4/2008

vandro Chagas-Fiocruz, which is affiliated with the HIV Prevention Trials Network (HPTN) and with the Adult Clinical Trials Group (ACTG) and the co-Principal Investigator for the National Institute of Child Health and Human Development (NICHD) perinatal clinical trials network.

Jacob P. Lalezari, MD, is the Director of Quest Clinical Research and an Assistant Clinical Professor of Medicine at UCSF/Mount Zion Hospital. Previously, he served as co-director of the HIV Clinical Research Center at Mt. Zion Medical Center and also at the University of California in San Francisco. Since 1989, Dr. Lalezari has served as a Principal Investigator for Phase 1, 2, and 3 clinical studies of new therapies for viral diseases including HIV/AIDS, CMV, HPV, HSV, Hepatitis B & C, Influenza, and RSV.

Graeme Moyle, MBBS, MD, is the Director of HIV Research Strategy at the Chelsea and Westminster Hospital, London. After graduating from the University of Adelaide, Australia, he moved to the United Kingdom and began working in HIV and AIDS working mostly at the Chelsea and Westminster Hospital but also gaining experience in HIV drug development, clinical trial design and management from within the pharmaceutical industry. He is a regular presenter of original research at international conferences, is the author of around 130 peer-reviewed publications on HIV, and Editor of The Journal of Viral Entry.

M. Keith Rawlings, MD, is Medical Director for the AIDS Arms/ Peabody Health Center in Dallas, Texas. Dr. Rawlings is currently Chair, Internal Medicine Section of the National Medical Association (NMA), and since 1994 has served as Co-Chair of the Infectious Diseases/ HIV program. Dr. Rawlings has provided direct comprehensive medical care to underserved individuals living with HIV for over 20 years.

Michael Saag, MD, is the Director of the Center for AIDS Research and the Division of Infectious Diseases and International Health in the Department of Medicine at the
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Ardea Biosciences Announces Changes to Research Management
3. Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
4. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
5. Ardea Biosciences Announces $40 Million Private Placement
6. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
9. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
10. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... November 27, 2014 Spartan Bioscience today ... Food and Drug Safety (MFDS) regulatory approval for its ... genetic results in less than 60 minutes from a ... as an aid for doctors to determine therapeutic strategies ... These include some of the world’s most commonly prescribed ...
(Date:11/27/2014)... England , November 27, 2014 ... online on ScienceDirect   Elsevier , ... products and solutions, is pleased to announce the launch ... . The launch of ... the rapid advances at the forefront of applied sciences ...
(Date:11/27/2014)... EDINBURGH , November 27, 2014 ... on revolutionising the management of tooth decay, today ... study of its Calcivis® Caries Activity Imaging System. ... is a sophisticated medical device and consumable combination ... dental caries (tooth decay). It involves a unique, ...
(Date:11/27/2014)... Massachusetts, USA (PRWEB) November 26, 2014 ... more accuracy, additive systems to enable 3D manufacture at ... analyzing road conditions are among finalists in nine categories ... . The awards are sponsored by SPIE, the ... Photonics Media . , Winners will be announced by ...
Breaking Biology Technology:Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 3Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 3Finalists Named for 2015 Prism Awards for Photonics Innovation 2Finalists Named for 2015 Prism Awards for Photonics Innovation 3Finalists Named for 2015 Prism Awards for Photonics Innovation 4Finalists Named for 2015 Prism Awards for Photonics Innovation 5
... Renowned Clinicians in the Fields of Cancer and Women,s Health ... to Best ... Address Current Medical Needs, REHOVOT, Israel and ... ROSG) announced,today the establishment of its Medical Advisory Board. Rosetta ...
... Pa., Feb. 4 Centocor, Inc. announced today,that ... 1275),has been accepted for review by the U.S. ... adult patients with chronic moderate to severe plaque,psoriasis. ... a novel,mechanism of action that targets the cytokines ...
... Aricept Prescription Rates, According to a New Report from Decision ... ... Feb. 4 Decision Resources, one of the,world,s leading research and ... owns a dominating,42.4% patient share for first-line treatment of newly diagnosed ...
Cached Biology Technology:Rosetta Genomics Establishes Medical Advisory Board 2Rosetta Genomics Establishes Medical Advisory Board 3Rosetta Genomics Establishes Medical Advisory Board 4Rosetta Genomics Establishes Medical Advisory Board 5Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA 2Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA 3Eisai/Pfizer's Aricept Owns a Dominating 42.4% Patient Share for First-Line Treatment of Alzheimer's Disease 2Eisai/Pfizer's Aricept Owns a Dominating 42.4% Patient Share for First-Line Treatment of Alzheimer's Disease 3
(Date:11/21/2014)... REDMOND, Wash. , Nov. 20, 2014 ... access for the Internet of Things (IoT), today announced ... position of chief operating officer. Previously a strategic advisor ... marketing, finance, and operations. Mr. Traynor is based out ... . He reports to Chris Muench , ...
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
(Date:11/7/2014)... Researchers led by Dr. Debra Auguste, associate professor, ... at The City College of New York, have ... treatment for one of the most aggressive forms ... (TNBCs) have a high mortality rate owing to ... effective therapeutic options. However, Professor Auguste,s team, discovered ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... The March of Dimes has extended its Prematurity Campaign ... address preterm birth globally. The expansion, announced at the ... the national action plan being created during the two-day ... birth. "The March of Dimes Prematurity Campaign has ...
... shot of youthful vigor in a stem cell experiment by ... for research on new treatments for age-related degenerative conditions such ... a new study to be published June 15 in an ... identified two key regulatory pathways that control how well adult ...
... has received $400,000 from the National Oceanic and Atmospheric ... system for the Mid-Atlantic region, spanning the waters from ... to the continental shelf. Nearly 25 percent of the ... initiative is part of the national Integrated Ocean Observing ...
Cached Biology News:March of Dimes announces Prematurity Campaign expansion at Surgeon General's conference 2March of Dimes announces Prematurity Campaign expansion at Surgeon General's conference 3Stem cell researchers give old muscle new pep 2Stem cell researchers give old muscle new pep 3Stem cell researchers give old muscle new pep 4UD nets NOAA funding for Mid-Atlantic ocean observing 2
Full service including gene cloning, protien expression and purification of 1 liter culture....
Superior homology search software - in all the flavours of blast, with increased sensitivity and speed...
Protein 3D structure prediction, via threading. Easy to use....
... (3 per pack), 1. One ... processing.Automated staining of Coomassie Blue or ... acid analysis.Prepares blots for high sensitivity ... of protocol, solution, volume, and processing ...
Biology Products: